daunorubicin has been researched along with geldanamycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brønstad, K; Døskeland, SO; Gausdal, G; Genieser, HG; Huseby, S; Keen, TJ; Kjærland, E; Kleppe, R; Krakstad, C; Kunick, C; Myhren, L; Schwede, F | 1 |
2 other study(ies) available for daunorubicin and geldanamycin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription.
Topics: Activating Transcription Factor 2; Animals; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Benzoquinones; Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element Modulator; Cyclic AMP-Dependent Protein Kinase Type I; Cyclic AMP-Dependent Protein Kinase Type II; Cyclin-Dependent Kinases; Daunorubicin; Drug Synergism; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Lactams, Macrocyclic; Leukemia; Membrane Proteins; Proto-Oncogene Proteins; Rats; RNA Interference; Transcription, Genetic | 2011 |